PCD Research is delighted to announce that the first research will be starting in Q4 2023.
2 year Post-doc position £250k in collaboration with the Nucleic Acid Therapeutic Accelerator (NATA)
Commencing Q4 2023 (currently hiring)
✓
mRNA Therapy
Investigate the delivery and optimisation of mRNA as a nucleic acid therapeutic, with the aim of restoring ciliary function.
✓
In vivo validation
In vivo validation using an inducible mouse model of loss of function of Ccdc39 in the second year, currently in production by the MRC funded Mary Lyon Centre, Harwell.